Condition: Hiv · Sponsor: CrescentCare
The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.
This description comes directly from the study's public registry record.
Narquis Barak, MS · 504.821.2601 · narquis.barak@crescentcare.org
Erin Meek, DrPH · 628-217-6113 · erin.wilson@sfdph.org
Always discuss trial participation with your own doctor first.
| NO/AIDS Task Force d.b.a. CrescentCare | New Orleans, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05689281